Join
Live feed
·
PRReleasevia Quantisnow
Viatris Inc. logo

Mapi Pharma Announces First Patient Recruited in Phase-I/II Study of Cariprazine Depot Once Monthly Injection

ByQuantisnow·Wall Street's wire, on your screen.
VTRS· Viatris Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VTRS (Viatris Inc.) and more on Quantisnow.